Minerva Advisors’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.27M | Buy |
93,058
+6,156
| +7% | +$348K | 3.45% | 10 |
|
|
2025
Q1 | $4.87M | Buy |
86,902
+8,513
| +11% | +$477K | 3.46% | 8 |
|
|
2024
Q4 | $4.82M | Buy |
78,389
+36,061
| +85% | +$2.22M | 2.82% | 12 |
|
|
2024
Q3 | $2.82M | Buy |
42,328
+34,794
| +462% | +$2.32M | 1.63% | 19 |
|
|
2024
Q2 | $503K | Buy |
+7,534
| New | +$503K | 0.34% | 36 |
|